IHS Chemical Week

Regions :: North America :: U.S.

Chemtura beats estimates, but bromine weakness persists

3:49 PM MDT | July 30, 2013 | Vincent Valk

Chemtura’s second-quarter net income from continuing declined 11% year-on-year (YOY), to $47 million, or 47 cts/share, on sales down 1%, to $735 million, the company says. Adjusted net income declined 25%, to 40 cts/share, but beat analysts’ consensus estimate of 37 cts/share, as reported by Thomson Reuters. Chemtura recorded an overall net loss, of $93 million, due to a $146 million loss related to the sale of its antioxidants business. Results were mostly in line with Chemtura’s reported preliminary results, issued earlier this month...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa